Treatment outcomes in methicillin-resistant <i>Staphylococcus aureus</i> bacteraemia patients receiving vancomycin: a retrospective study at a tertiary hospital

Vancomycin AUC/MIC attainment was suboptimal, and mortality was primarily influenced by host factors and disease severity. Early risk stratification and timely intervention are critical to improve outcomes and guide resource prioritisation, particularly in settings with limited access to AUC-guided dosing.